Back to top

Image: Bigstock

Tech Stocks' May 6 Earnings Roster: SHOP, SQ, ANSS & More

Read MoreHide Full Article

Technology stocks’ first-quarter results are expected to reflect broad-based uptick in demand for cloud computing solutions and digital transformation techniques triggered by the coronavirus-pandemic.

However, weakness in automobile and PC verticals due to the coronavirus-induced economic crisis and supply chain disruption is likely to have weighed on the business prospects of the technology companies in the first quarter. The coronavirus outbreak has dampened sales with millions under lockdown. (Read More: PC Shipments Fall in Q1 on Coronavirus-Led Supply-Chain Woes)

Moreover, sluggishness in consultation and lower ad-spending amid slowdown in IT spending might have limited growth for the Internet-based tech companies in the first quarter. (Read More: Coronavirus-Led Slowdown to Hurt Corporate IT Spending – IDC)

Nevertheless, coronavirus-induced work-from-home wave is likely to have bolstered sales of processors utilized in enterprise laptops and data center servers. This, in turn, is expected to have benefited the technology sector in the to-be-reported quarter. Markedly, both AMD and Intel gained from robust adoption of high-performance processors in the first quarter.

Besides, work-from-home trend is likely to have benefited the companies offering video conferencing tools and workspace management offerings.

For instance, Microsoft's (MSFT - Free Report) third-quarter fiscal 2020 results gained from momentum in Azure, impressive Teams user growth led by coronavirus-induced work-from-home wave and uptick in Surface devices. (Read more: Microsoft Q3 Earnings & Revenues Beat Estimates, Up Y/Y)

Further, stay-at-home wave is likely to have driven adoption of cloud computing solutions, including contactless payment, online education portals, cloud-gaming, social media platforms, and other leisure tools.

Glimpse on Few Upcoming Q1 Releases

Given this mixed backdrop, investors interested in the tech sector companies keenly await quarterly reports from notable companies slated to report on May 6.

Our proven model predicts an earnings beat for Shopify Inc. (SHOP - Free Report) in first-quarter 2020. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an earnings beat.

Shopify has an Earnings ESP of +23.41% and a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank stocks here.

The company’s first-quarter 2020 performance is anticipated to have benefited from increasing adoption of merchant-friendly applications and strong online sales triggered by the coronavirus outbreak.

Moreover, adoption of “multi-currency feature” aimed at enabling merchants to sell products in several currencies and receive payments in their respective local currency might have driven Shopify Plus revenues in the quarter to be reported. (Read More: Shopify to Report Q1 Earnings: Is a Beat in the Cards?)
 

Shopify Inc. Price and EPS Surprise

Shopify Inc. Price and EPS Surprise

Shopify Inc. price-eps-surprise | Shopify Inc. Quote

The consensus for first-quarter earnings is pegged at loss of 18 cents per share, which narrowed from a loss of 19 cents in the past 30 days.

Square's (SQ - Free Report) first-quarter 2020 results are likely to reflect strength in product and services portfolio despite coronavirus woes.

Notably, Square has an Earnings ESP of +2.15% and a Zacks Rank #3.

The company’s strong product lines including Square Invoices, Instant Deposits, Cash Card, Square Point of Sale, Square Online Store, Square Reader, Square Photo Studio, Order Manager, Square Payroll and Square Stand are expected to have driven the first-quarter performance. (Read More: Square to Report Q1 Earnings: What's in the Offing?)
 

Square, Inc. Price and EPS Surprise

Square, Inc. Price and EPS Surprise

Square, Inc. price-eps-surprise | Square, Inc. Quote

The Zacks Consensus Estimate for first-quarter earnings is pegged at 13 cents per share, which has been stable over the past seven days, suggesting an improvement of 18.2% year over year.

ANSYS' (ANSS - Free Report) first-quarter 2020 results are likely to reflect gains from robust demand of its simulation solutions in the medical devices market. This trend is expected to have continued in the first quarter owing to large demand for medical devices due to the coronavirus pandemic.

Notably, ANSYS has an Earnings ESP of +2.14% and a Zacks Rank #3.

Moreover, strong synergies from its partnerships with Autodesk, Microsoft and Rockwell Automation are likely to have aided the company in acquiring more customers. This, in turn, is expected to have benefited first-quarter performance. (Read More: Is a Beat in the Cards for ANSYS in Q1 Earnings?)

 

ANSYS, Inc. Price and EPS Surprise

ANSYS, Inc. Price and EPS Surprise

ANSYS, Inc. price-eps-surprise | ANSYS, Inc. Quote

The Zacks Consensus Estimate for first-quarter earnings is pegged at 78 cents per share, unchanged in the past 30 days.

Fortinet's (FTNT - Free Report) first-quarter 2020 results are expected to have benefited from strong momentum in FortiGate virtual machines, which is driving its private and public cloud billings.

Moreover, to contain the coronavirus's spread, a huge global workforce is working remotely. This trend might have driven demand for Fortinet’s network security products in the first quarter. (Read More: Fortinet to Post Q1 Earnings: What's in the Offing?)

Fortinet has an Earnings ESP of 0.00% and a Zacks Rank #3. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.

 

Fortinet, Inc. Price and EPS Surprise

Fortinet, Inc. Price and EPS Surprise

Fortinet, Inc. price-eps-surprise | Fortinet, Inc. Quote

The Zacks Consensus Estimate for first-quarter earnings is pegged at 50 cents per share, down almost 2% in the past seven days. However, the figure suggests an improvement of 8.7% year over year.

PayPal Holdings, Inc. (PYPL - Free Report) first-quarter 2020 results are likely to reflect gains from portfolio strength. Robust mobile checkout services of One Touch are expected to have contributed to the company’s total payment volume growth.

Further, Venmo’s improving monetization efforts are likely to have bolstered adoption rate and driven total active accounts in the first quarter.

However, coronavirus related uncertainties and disruptions are anticipated to get reflected in the company’s first-quarter results. (Read More: PayPal to Report Q1 Earnings: What's in the Offing?)

PayPal has an Earnings ESP of -3.16% and a Zacks Rank #3.

 

PayPal Holdings, Inc. Price and EPS Surprise

PayPal Holdings, Inc. Price and EPS Surprise

PayPal Holdings, Inc. price-eps-surprise | PayPal Holdings, Inc. Quote

The Zacks Consensus Estimate for first-quarter earnings stands at 76 cents per share, unchanged in the past seven days.

CDW Corporation’s (CDW - Free Report) first-quarter 2020 results are likely to reflect declines in both enterprise storage and servers, which might have dampened data center hardware growth. Further, the passage of Windows 10 replacement cycle may have hindered growth.

However, strength across end markets, particularly small business, government and healthcare, and synergies from the Scalar acquisition deal to further fortify its footprint in Canada are expected to have limited the overall decline.

The company currently carries a Zacks Rank #4 (Sell).

 

CDW Corporation Price and EPS Surprise

CDW Corporation Price and EPS Surprise

CDW Corporation price-eps-surprise | CDW Corporation Quote

The consensus for first-quarter earnings stands at $1.36 per share, unchanged in the past seven days.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

Published in